The orthomolecular treatment of cancer. I. The role of ascorbic acid in host resistance |
| |
Authors: | E Cameron L Pauling |
| |
Institution: | 1. Institute of Orthomolecular Medicine, 2700 Sand Hill Road, Menlo Park, Calif.U.S.A.;2. Department of Clinical Research, Vale of Leven District General Hospital, AlexandriaScotland |
| |
Abstract: | Natural resistance to neoplastic disease governs the incidence of clinical cancer and influences the individual's response to standard methods of treatment. Supportive measures, specifically designed to enhance the natural resistance of the host, should diminish cancer incidence, morbidity and mortality. The various factors involved in host resistance are briefly reviewed, and it is contended that the availability of ascorbic acid plays an important role in many of these physiological processes. The potential value of ascorbic acid in the supportive treatment of cancer is a matter for urgent study at many levels. It offers the promise of general improvement in the results of cancer management, including prophylaxis in general, supportive therapy when standard methods of treatment are being used, and palliative treatment in advanced terminal cancer. |
| |
Keywords: | PHI physiological hyaluronidasc inhibitor |
本文献已被 ScienceDirect 等数据库收录! |
|